Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

  • Soler Vázquez, M. Carmen|||0000-0003-1430-5617
  • Romero, María del Mar|||0000-0001-6274-5743
  • Todorcevic, Marijana
  • Delgado, Katia
  • Calatayud, Carles|||0000-0003-0032-4198
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Mera, Paula|||0000-0001-8941-4637
  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Bastías Pérez, Marianela|||0000-0003-0098-8090
  • Ibeas, Kevin
  • Casals, Nuria|||0000-0002-6719-4300
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Consiglio, Antonella
  • Serra, Dolors|||0000-0002-4936-4206
  • Herrero, Laura|||0000-0003-4244-4673
Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach.